{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:07:14Z","timestamp":1781327234201,"version":"3.54.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"vor","delay-in-days":225,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.5604\/01.3001.0012.7188","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T06:29:00Z","timestamp":1541399340000},"page":"899-902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["The evolving role of liver biopsy in non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Juan Pablo","family":"Arab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Arrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.5604\/01.3001.0012.7188_bib0005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7188_bib0010","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.7188_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl. 1","key":"10.5604\/01.3001.0012.7188_bib0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/liv.13653","article-title":"Diagnosis of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: Why liver biopsy is essential","volume":"38","author":"Bedossa","year":"2018","journal-title":"Liver Int"},{"issue":"Suppl. 1","key":"10.5604\/01.3001.0012.7188_bib0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/liv.13658","article-title":"Diagnosis of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: Non-invasive tests are enough","volume":"38","author":"Castera","year":"2018","journal-title":"Liver Int"},{"key":"10.5604\/01.3001.0012.7188_bib0030","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/hep4.1055","article-title":"Nonalcoholic fatty liver disease and the ongoing role of liver biopsy evaluation","volume":"1","author":"Brunt","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.5604\/01.3001.0012.7188_bib0035","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jhep.2017.09.024","article-title":"Back to Byzance: Querelles byzantines over NASH and fibrosis","volume":"67","author":"Ratziu","year":"2017","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.7188_bib0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"10.5604\/01.3001.0012.7188_bib0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.7188_bib0050","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7188_bib0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cld.2017.08.006","article-title":"The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom","volume":"22","author":"Gunn","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.5604\/01.3001.0012.7188_bib0060","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7188_bib0065","doi-asserted-by":"crossref","unstructured":"Pelusi S, Valenti L. Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease. Liver Int 2018; in press.","DOI":"10.1111\/liv.13972"},{"key":"10.5604\/01.3001.0012.7188_bib0070","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","journal-title":"J Hepatol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119310506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119310506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:38:54Z","timestamp":1761647934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119310506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1665268119310506"],"URL":"https:\/\/doi.org\/10.5604\/01.3001.0012.7188","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolving role of liver biopsy in non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.5604\/01.3001.0012.7188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}